![Jónas Einarsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jónas Einarsson
Vorstandsvorsitzender bei
Radiumhospitalets Forskningsstiftelse
Profil
Jónas Einarsson currently works at Radiumhospitalets Forskningsstiftelse, as Chief Executive Officer from 2000, Radforsk Investeringsstiftelse, as Chief Executive Officer, Ultimovacs ASA, as Chairman from 2011, Nucligen AS, as Director, and Occi Holding AS, as Director.
Dr. Einarsson also formerly worked at Oslo Cancer Cluster NCE, as Chief Executive Officer, Circio Holding ASA, as Chairman from 2010 to 2017, Hubro Therapeutics AS, as Chairman, Biomolex AS, as Director, Nordic Nanovector ASA, as Independent Director, and Oncoinvent ASA, as Director.
Dr. Einarsson received his doctorate degree from the University of Oslo and doctorate degree from Reykjavik University.
Aktive Positionen von Jónas Einarsson
| Unternehmen | Position | Beginn |
|---|---|---|
Radiumhospitalets Forskningsstiftelse
 Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Invests in companies from Nordic research institutions | Vorstandsvorsitzender | 15.06.2009 |
Nucligen AS | Direktor/Vorstandsmitglied | - |
Occi Holding AS
 Occi Holding AS Real Estate DevelopmentFinance Leases real estate properties | Direktor/Vorstandsmitglied | - |
Radforsk
 Radforsk Financial ConglomeratesFinance Operates as a life science investment company | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Jónas Einarsson
| Unternehmen | Position | Ende |
|---|---|---|
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Direktor/Vorstandsmitglied | 04.02.2022 |
Hubro Therapeutics AS
 Hubro Therapeutics AS BiotechnologyHealth Technology Develops immunotherapies and neo-antigen vaccines for treatment of cancer | Vorsitzender | - |
Ultimovacs ASA
 Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Vorsitzender | - |
| CIRCIO HOLDING ASA | Vorsitzender | 30.11.2017 |
Biomolex AS
 Biomolex AS Medical SpecialtiesHealth Technology Develops and delivers imaging systems for digital autoradiography | Direktor/Vorstandsmitglied | - |
Ausbildung von Jónas Einarsson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Oslo Cancer Cluster NCE
 Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Operates as oncology research firm, which develops cancer diagnostics and medicines | Commercial Services |
Radiumhospitalets Forskningsstiftelse
Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Invests in companies from Nordic research institutions | Finance |
Biomolex AS
Biomolex AS Medical SpecialtiesHealth Technology Develops and delivers imaging systems for digital autoradiography | Health Technology |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reykjavik University
 Reykjavik University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
Nucligen AS | |
Hubro Therapeutics AS
Hubro Therapeutics AS BiotechnologyHealth Technology Develops immunotherapies and neo-antigen vaccines for treatment of cancer | Health Technology |
Occi Holding AS
Occi Holding AS Real Estate DevelopmentFinance Leases real estate properties | Finance |
Radforsk
Radforsk Financial ConglomeratesFinance Operates as a life science investment company | Finance |
